-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On Silence Therapeutics with Overweight Rating

Benzinga·06/24/2026 14:01:56
Listen to the news
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Silence Therapeutics (NASDAQ:SLN) with a Overweight rating.